Cellebrite Wins Significant Open-Source Intelligence Solutions Customer Contract
New deal reinforces Cellebrite’s market leadership as law enforcement organizations preferred end-to-end technology partner to modernize their entire investigative workflow
PETAH TIKVA, ISRAEL and TYSONS CORNER, VA, January 10, 2022 – Cellebrite (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced that it has won a significant Open-Source Intelligence (“OSINT”) customer contract following the Company’s acquisition of Digital Clues in November 2021. The new customer contract is a multi-year contract with initial value of US$1.5 million for the first year and is the most noteworthy SaaS deal for Cellebrite to date.
Cellebrite’s OSINT solution, part of the Company’s industry leading investigative DI Platform, is aimed at supporting the early stages of law enforcement investigations, irrespective of whether the investigative teams have a lead or not, by quickly enabling them to collect and connect large amounts of fragmented digital evidence from many dynamic sources, including the surface web, deep web, and dark web. The adoption of the OSINT solution is being driven by its use by law enforcement agencies as they increase their efforts to stop crimes against children, drug and human trafficking, organized crime, and terrorism. The new customer selected Cellebrite’s OSINT solutions to replace its existing system because of the OSINT solutions’ unmatched capabilities, ability to adapt quickly to rapidly changing open-source repositories, and ease of use.
“We are pleased with the early success reflected by this significant, multi-year contract that demonstrates our ability to provide end-to-end investigative workflow solutions to law enforcement which help to make our communities safer,” said Alon Klomek, Cellebrite’s Chief Business Officer. “With our scalable and innovative cloud offerings, Cellebrite is able to partner with law enforcement agencies to address their growing demand for solutions that kickstart their investigation efforts by legally and ethically collecting open-source data in criminal investigations.”
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com and https://investors.cellebrite.com.
Caution Regarding Forward-Looking Statements
This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of the business of Cellebrite are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to develop technologically advanced solutions and successfully integrate with the software solutions used by customers; acceptance of solutions by customers; errors, failures, defects or bugs in solutions; a failure to maintain sales and marketing personnel productivity or hire, integrate and retain additional sales and marketing personnel; the impact of the global COVID-19 pandemic; the impact of competition on pricing and on Cellebrite’s market share; sub-optimal results from products due to misuse by customers; Cellebrite’s failure to maintain and enhance its reputation and brand; inaccuracy of the estimates of Cellebrite’s market opportunity and forecasts of market growth; changes to packaging and licensing models that adversely affect the ability to attract or retain customers; failure to manage future growth effectively; failure to introduce new solutions and add-ons; issues in the use of artificial intelligence resulting in reputational harm or liability; the need for additional capital to support the growth of Cellebrite’s business; a failure to maintain the security of operations and the integrity of software solutions; the impact of government budgeting cycles and appropriations, early termination, audits, investigations, sanctions and penalties; a decline in government budgets, changes in spending or budgetary priorities, or delays in contract awards; a failure to adequately obtain, maintain, protect and enforce Cellebrite’s intellectual property or infringement of the intellectual property rights of others; perceptions or court or regulatory decisions that Cellebrite’s solutions violate privacy rights; the use of solutions by customers in a way that is, or that is perceived to be, incompatible with human rights; failure to comply with laws regarding privacy, data protection and security, technology protection, sanctions, export controls and other matters; and other factors, risks and uncertainties set forth in the sections titled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the final proxy statement/prospectus relating to Cellebrite’s consummated business combination filed with the SEC on August 5, 2021 and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
VP Investor Relations
+972 73 394 8440